Failure to perceive increased risk of fracture in women 55 years and older : the Global Longitudinal Study of Osteoporosis in Women (GLOW), Osteoporos Int, issue.1, pp.22-27, 2011. ,
Adherence to bisphosphonate therapy and fracture rates in osteoporosic women : relationship to vertebral and nonvertebral fractures from 2 US claims databases, Mayo Clin. Proc, issue.8, pp.81-1013, 2006. ,
Exploring successful community pharmacist-physician collaborative working relationships using mixed methods, Res. Social Adm. Pharm, vol.6, issue.4, pp.307-323, 2010. ,
Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA), Arch. Osteoporos, vol.6, issue.12, pp.59-155, 2011. ,
Primary care physicians' perceptions of medication errors and error prevention in cooperation with community pharmacists, Res. Social Adm. Pharm, vol.7, issue.2, pp.162-179, 2011. ,
la file active sera de 40 patients qui seront suivis jusqu'en 2016 (patients inclus, 2013. ,
Ostéoporose post-ménopausique et ses enjeux ; Solid'os, 2010. ,
Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporosis International, vol.13, issue.12, pp.1475-80, 2005. ,
DOI : 10.1016/S0020-1383(99)00248-X
Long-Term Social Prognosis after Hip Fractures, Acta Orthopaedica Scandinavica, vol.3, issue.1, pp.97-101, 1982. ,
DOI : 10.1136/bmj.3.5928.456
URL : http://www.tandfonline.com/doi/pdf/10.3109/17453678208992185?needAccess=true
Adherence to biphosphonate therapy is associated with decreased nonvertebral osteoporotic fracture risk, J.Bone and Mineral Research, vol.20, 2005. ,
Siris EValue Health. A meta-analysis of osteoporotic fracture risk with medication nonadherence, pp.571-81, 2011. ,
Hôpital Saint-Antoine (APHP), Paris, Education thérapeutique et ostéoporose, 2011. ,
Prévention et traitement de l'ostéoporose: éviter l'inertie clinique et motiver l'adhésion au traitement, Rev Med Liège, vol.65, pp.5-6, 2010. ,
Note de synthèse HAS, juillet, 2006. ,
Compliance with drug therapy for postmenopausal osteoporosis, Osteoporosis International, vol.42, issue.8, pp.1645-52, 2006. ,
DOI : 10.7326/0003-4819-132-11-200006060-00026
La prise en charge de l'ostéoporose après fracture de basse énergie : l'intérêt des filières en milieu hospitalier. Réalités en rhumatologie, 41, janv, pp.4-9, 2012. ,
Coordinator-based systems for secondary prevention in fragility fracture patients, Osteoporosis International, vol.7, issue.2, pp.2051-65, 2011. ,
DOI : 10.1007/s00198-002-1336-5
Is osteoporosis disease management cost effective? Curr Osteoporos Rep, pp.49-55, 2010. ,
DOI : 10.1007/s11914-010-0009-0
Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8??years of service provision, Osteoporosis International, vol.3, issue.4, pp.2083-98, 2011. ,
DOI : 10.1383/wohm.2006.3.4.149
The role of physical activity in the prevention of osteoporosis in postmenopausal women???An update, Maturitas, vol.63, issue.1, pp.34-42, 2009. ,
DOI : 10.1016/j.maturitas.2009.03.002
Prévention et traitement de l'ostéoporose: éviter l'inertie clinique et motiver l'adhésion au traitement, Rev Med Liège, vol.65, pp.5-6358, 2010. ,
Analysis of the Comparative Effectiveness of 3 Oral Bisphosphonates in a Large Managed Care Organization: Adherence, Fracture Rates, and All-Cause Cost, Journal of Managed Care Pharmacy, vol.17, issue.8, pp.596-609, 2011. ,
DOI : 10.18553/jmcp.2011.17.8.596
Long-Term Social Prognosis after Hip Fractures, Acta Orthopaedica Scandinavica, vol.3, issue.1, pp.97-101, 1982. ,
DOI : 10.1136/bmj.3.5928.456
URL : http://www.tandfonline.com/doi/pdf/10.3109/17453678208992185?needAccess=true